List of Top Largest Pharmaceutical Companies in India

India is also known as the Pharmacy of the world. It is so because India is one of the leading exports of pharmaceutical products in the world. Last year, India exported the pharmacy worth $20 billion which is a record in itself. The reason why India is doing so well in this industry is the presence of top pharma companies in India that manufacture medicines of the finest quality. Apart from medicines, India fulfills 50% of the vaccine demand of the world. In this post, we are going to list the top 10 pharma company in India in 2023 on the basis of total net sales.

List of 10 best Pharmaceutical Companies in India 2023

Please note that we are ranking these top 10 Pharmaceutical Companies in India in 2023 on the basis of their total sales in the previous year.

10 Divi’s Laboratories Ltd.

  • Market Cap: 57,919 Cr.
  • ROE: 21.01 %
  • Sales Growth (3Yrs): 9.41 %
  • Promoter holding: 52.00 %
  • Debt to equity: 0.00
  • Price to book value: 8.18
  • Revenue in the year 2020 – ₹5,584.05 crores (US$780 million)
  • Founded – 1990
  • Headquarters – 1-72/23(P)/DIVIS/303, Divi Towers Cyber Hills, Gachibowli 500032, Hyderabad, Telangana, India
  • Products – Naproxen, Gabapentin, Dextromethorphan HBr
  • Key People – Murali Krishna Prasad Divi (MD), Satchandra Kiran Divi (CEO)

Established in the year 1990, Divi’s Laboratories is one of the most renowned pharmaceutical manufacturers in India. Early, the company was named Divi’s Research Centre. Currently, the company has six manufacturing facilities and three R&D centres across India. The main products developed by Divi’s Laboratories are Naproxen, Gabapentin, Dextromethorphan Hbr. There are 350 scientists and 11000 highly trained professionals working at Divi Laboratories. The revenue collected by the company in the last year is around Rs. 5,584.05 crore (US$780 million).

9 Alkem Laboratories Ltd.

  • Market Cap: 30,691 Cr.
  • ROE: 14.84 %
  • Sales Growth (3Yrs): 14.47 %
  • Promoter holding: 66.04 %
  • Debt to equity: 0.24
  • Price to book value: 5.22
  • Revenue in the year 2020 – ₹84,485 million (US$1.2 billion)
  • Founded – 1973
  • Headquarters – Mumbai, Maharashtra, India
  • Products – Pharmaceuticals, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health
  • Key People – Basudeo Narayan Singh (Executive Chairman), Sandeep Singh (MD)

Alkem Laboratories Limited is one the leading pharmaceutical companies As of now, Alkem has 21 manufacturing facilities – 19 in India and 2 in the United States. In the year 2020, the company gathered huge revenue of Rs. 84, 485 million. The portfolio of Alkem includes 705 branded generic drugs, with 13 of the brands featured among the top 300 brands in India. The founder of Alkem Laboratories was Mr. Samprada Singh. He was the 42nd richest person in India. The executive chairman of the company was Mr. Basudeo Narayan Singh. Right now, there are around 14, 331 employees working for the company.

8 Torrent Pharmaceutical Ltd.

  • Market Cap: 35,530 Cr.
  • ROE: 12.75 %
  • Sales Growth (3Yrs): 4.69 %
  • Promoter holding: 71.25 %
  • Debt to equity: 0.85
  • Price to book value: 7.00
  • Revenue in the year 2020 – ₹8,060 crores (US$1.1 billion)
  • Founded – 1959
  • Headquarters – Ahmedabad, India
  • Products – Pharmaceuticals, generic drugs, over-the-counter, drugs, vaccines, diagnostics, contact lenses, animal health
  • Key People – Sudhir Mehta, Samir Mehta

Torrent Pharmaceutical Ltd. is a part of Torrent Group. It is a billion-dollar company renowned not only in India but also around the world. It is a highly reputed company that is working in more than 40 countries selling over 2000 globally registered products. The fully owned subsidiaries of Torrent Pharmaceutical Ltd. are Heumann Pharma GmbH & Co Generica KG, Germany, Torrent Pharma GmbH, Germany, Torrent do Brasil Ltda., Brazil, ZAO Torrent Pharma, Russia, Torrent Pharma Inc., United States, Torrent Pharma Philippines Inc., Philippines, Torrent Pharma Canada Inc., Canada, Torrent Pharma UK United Kingdom.

7 Glenmark Pharmaceutical Ltd.

  • Market Cap: 7,505 Cr.
  • ROE: 15.20 %
  • Sales Growth (3Yrs): 9.27 %
  • Promoter holding: 46.59 %
  • Debt to equity: 0.60
  • Price to book value: 1.27
  • Revenue in the year 2020 – Rs. 23,447.87 Mn. (USD 311.03 Mn.)
  • Founded – 1977
  • Headquarters – Mumbai
  • Products – Innovative/ Specialty, Generics and OTC business in the therapy areas of Dermatology, Respiratory and Oncology.
  • Key People – Mr. Yasir Rawjee.

Founded in the year 1977 by Gracias Saldanha, Glenmark Pharmaceutical Ltd. is also a reputed name in the field of pharmacy. In the year 2020, the company gained a lot of fame when it released a potential COVID-19 drug Favipiravir under the brand name FabiFlu in India. Currently, the company is also working on the advanced version of FabiFlu. The founder of Glenmark Pharmaceutical Ltd. is one of the richest persons in India. The current CEO of this company is Mr. Yasir Rawjee.

6 Zydus Cadila Healthcare Ltd.

  • Market Cap: 26,228 Cr.
  • ROE: 18.66 %
  • Sales Growth (3Yrs): 11.78 %
  • Promoter holding: 74.88 %
  • Debt to equity: 0.69
  • Price to book value: 2.55
  • Revenue in the year 2020 – ₹15,139 crores (US$2.1 billion)
  • Founded – 1952 (69 years ago)
  • Headquarters – Ahmedabad, Gujarat, India
  • Products – Pharmaceuticals, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health
  • Key People – Pankaj R. Patel, Chairman, Sharvil P. Patel, MD

Ahmedabad-based, Zydus Cadila Healthcare Ltd. is also one of the biggest and oldest pharma companies in India 2023. It was established in the year 1952 by Mr. Ramanbhai Patel. Along with the pharma products, Zydus Cadila is also instrumental in the manufacturing of herbal products, skincare products, and other OTC products. There are three main manufacturing plants of Zydus Cadila i.e. Ankleshwar plants, Vadodara plant, and Patalganga plant. Soon, the company is going to launch its covid – 19 vaccine by the name ZyCoV-D.

5 Dr. Reddy’s Laboratories Ltd.

  • Market Cap: 50,867 Cr.
  • ROE: 13.61 %
  • Sales Growth (3Yrs): -0.26 %
  • Promoter holding: 26.76 %
  • Debt to equity: 0.17
  • Price to book value: 3.30
  • Revenue in the year 2020 – Increase ₹17,460 crores (US$2.4 billion)
  • Founded – 1984
  • Headquarters – Hyderabad, Telangana, India
  • Products – Pharmaceuticals, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health
  • Key People – V. Prasad (Co-Chairman & MD), Kallam Satish Reddy (Chairman), Erez Israeli (CEO)

Hyderabad, Telangana, based Dr. Reddy’s Laboratories Ltd. is also one of the pharmaceutical giants in the world. As of 2023, there are more than 21, 650 employees working for this company. Dr. Reddy’s pharma company was launched in 1984 producing active pharma products.  In March 2002, Dr. Reddy’s acquired Beverley, BMS Laboratories, and its wholly-owned subsidiary Meridian Healthcare, for 14.81 million Euros. The deal makes Dr. Reddy one of the biggest pharma companies in the world. Dr. Reddy is also famous for launching “Purple Health” in India, it is a patient-centric platform to deliver solutions that address the unmet needs of patients.

4 Cipla

  • Market Cap: 34,358 Cr.
  • ROE: 9.62 %
  • Sales Growth (3Yrs): 5.87 %
  • Promoter holding: 36.65 %
  • Debt to equity: 0.23
  • Price to book value: 2.20
  • Revenue in the year 2020 –
  • Founded – 1935
  • Headquarters – Mumbai, Maharashtra
  • Products – Pharmaceuticals and diagnostics
  • Key People – Y. K. Hamied (Chairman), Umang Vohra (CEO)

Cipla is a well-known name in the world of pharmacy. It primarily develops medicines to treat respiratory, cardiovascular disease, arthritis, diabetes, weight control, and depression; other medical problems. The main goal of Cipla is to make sure that no patient is denied access to high-quality & affordable medicine and support. This company was founded in the year 2002 as Enaleni Pharmaceuticals Ltd. Later on, the company acquired Cipla – Medpro a South African generic company.

3 Lupin Pharmaceutical Ltd.

  • Market Cap: 29,497 Cr.
  • ROE: 5.38 %
  • Sales Growth (3Yrs): 5.46 %
  • Promoter holding: 46.93 %
  • Debt to equity: 0.64
  • Price to book value: 2.17
  • Revenue in the year 2020 – ₹158,585 million (US$2.2 billion)
  • Founded – Desh Bandhu Gupta
  • Headquarters – Mumbai, Maharashtra, India
  • Products – Pharmaceuticals, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health
  • Key People – Vinita D. Gupta (CEO), Nilesh Gupta (MD)

The Founder of Lupin Pharmaceutical Ltd. is Mr. Desh Bandhu Gupta, who launched this company in the year 1968. Currently, the company sells high-quality pharma products to more than 70 companies. Lupin Pharmaceutical Ltd. has a stronghold in markets like the USA, Europe, Japan, Australia along with emerging markets including India, Philippines, and South Africa. Apart from this, the company is also involved in many social welfare programs such as Lupin Human Welfare & Research Foundation (LHWRF).

2 Aurobindo Pharma Ltd.

  • Market Cap: 27,615 Cr.
  • ROE: 19.01 %
  • Sales Growth (3Yrs): 12.41 %
  • Promoter holding: 51.87 %
  • Debt to equity: 0.37
  • Price to book value: 1.82
  • Revenue in the year 2020 – ₹23,290 crores (US$3.3 billion)
  • Founded – 1986
  • Headquarters – Hyderabad, Telangana, India
  • Products – Pharmaceuticals, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health.
  • Key People – V. Ramprasad Reddy, K. Nityananda Reddy

Established in the year 1988-89 with a single unit manufacturing semi-synthetic penicillin (SSP) in Puducherry, Aurobindo Pharma is a public company. According to many experts, Aurobindo Pharma is amongst the top 10 pharma companies in India in terms of consolidated revenues. Right now, the products of this company are exported to more than 125 countries. The marketing partners of Aurobindo Pharma include AstraZeneca and Pfizer.

1 Sun Pharmaceutical Industries Ltd.

  • Market Cap: 94,378 Cr.
  • ROE: 9.19 %
  • Sales Growth (3Yrs): 0.67 %
  • Promoter holding: 54.56 %
  • Debt to equity: 0.25
  • Price to book value: 2.28
  • Revenue in the year 2020 – ₹334.73 billion (US$4.7 billion)
  • Founded – 1983
  • Headquarters – Mumbai, Maharashtra, India
  • Products – Pharmaceuticals, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health
  • Key People – Dilip Shanghvi (CEO)

Sun Pharmaceuticals was founded rather modestly by Dilip Shanghvi in the year 1983. As per a report published in the year 2014, Sun pharma is the largest Pharma company in India and the 5th largest specialty generic company globally. Currently, Sun is the third-largest producer in the world in terms of volume. In a report published by BlueBytes, Sun Pharma is the second Most reputed brand in India. Due to all these reasons, we can say Sun Pharmaceutical is the best Pharma Company in India.

Frequently Asked Questions

Question – 1: What are the top pharma companies in Bangalore?

Answer: Some of the top pharmaceutical companies in Bangalore are as follows.

  • Aurigene Discovery Technologies Limited
  • Bal Pharma Limited
  • Terzetto Pharma Metrics
  • Novo Nordisk India
  • Lotus Labs Private Limited

Question – 2: Can you name some of the best pharmaceutical companies in Hyderabad?

Answer: The list of top pharma companies in Hyderabad are as follows.

  • Reddy’s Laboratories Ltd
  • Sri Krishna Pharmaceuticals Limited
  • Aurobindo Pharma Ltd
  • Divi’s Laboratories Ltd
  • Biological E. Limited

Question – 3: Apart from the list mentioned in this post, what other top pharma companies in India?

Answer: A few of the other top pharma companies in India are as follows.

  • Piramal Enterprises Limited
  • Mankind Pharma Limited
  • Biopharm Lifesciences Pvt. Ltd.
  • Innovexia Life Sciences Pvt. Ltd.
  • Intas Pharmaceuticals Limited
  • Biocon Limited

Question – 4: Which is the No 1 pharma company in India?

Answer: As per the revue and value, Sun Pharmaceutical Industries Ltd. is the number 1 pharma company in India.

Spread the Knowledge

Leave a Reply

Your email address will not be published. Required fields are marked *